Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Responsible for providing interim coverage of open sales territories, including all aspects of sales territory management - including selling specialty Neurology product to Movement Disorder Specialists and Neurologists. Able to move within the U.S. as business needs dictate. Interim coverage would likely span a 1-6 month period and then role would be reassigned to a different opening for a 1-6 month span of time. Once this individual has performed successfully in role for 12 months, they will be eligible to apply for any open territory in United States for a full-time, long-term territory assignment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level